Presentation Information

[28-20-am04]Evaluation of efficacy and hematologic toxicity of BRD4/CBP/p300 combined inhibition for pediatric MLL-rearranged acute lymphoblastic leukemia

○Natsuki Imayoshi1,2, Kyona Yamamoto1,3, Mio Shimada1,3, Masahiro Tsuda1,3, Tomohiro Terada1, Eishi Ashihara2 (1. Dept. Clin. Pharmacol. Ther., Kyoto Univ. Hosp., 2. Lab. of Clin. Transl. Physiol., Kyoto Pharmaceutical Univ., 3. Grad. Sch. Pharm. Sci., Kyoto Univ.)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.